Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian M Jespersen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trialJørgen Hilden, Inga Lind, Hans Jørn Kolmos, et al.
BMJ (Clinical Research Ed.)|December 13, 2005
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trialChristian M Jespersen, Bodil Als-Nielsen, Morten Damgaard, et al.
Journal of Cardiovascular Pharmacology|November 19, 2009
Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart diseaseGorm B Jensen, Jørgen Hilden, Bodil Als-Nielsen, et al.
Cardiology|May 3, 2008
Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart diseaseChristian Gluud, Bodil Als-Nielsen, Morten Damgaard, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trialJørgen Hilden, Inga Lind, Hans Jørn Kolmos, et al.
BMJ (Clinical Research Ed.)|December 13, 2005
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trialChristian M Jespersen, Bodil Als-Nielsen, Morten Damgaard, et al.
Journal of Cardiovascular Pharmacology|November 19, 2009
Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart diseaseGorm B Jensen, Jørgen Hilden, Bodil Als-Nielsen, et al.
Cardiology|May 3, 2008
Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart diseaseChristian Gluud, Bodil Als-Nielsen, Morten Damgaard, et al.
Pageof 2